SolomonCDSteelJGSpaccaventoLJ. Verapamil prophylaxis of migraine. JAMA1983; 250: 2500–2.
2.
SchwartzMLRotmenschHHVlassesPHFergusonRK. Calcium blockers in smooth muscle disorders: Current status. Arch Intern Med1984; 144: 1425–9.
3.
WeerasuriyaKPatelLTurnerP. β-adrenoceptor blockade and migraine. Cephalalgia1982; 2: 33–45.
4.
CouchJR. Amitriptyline in the prophylaxis of migraine. Neurology1976; 26: 121.
5.
CouchJR. Amitriptyline in migraine prophylaxis. Arch Neurol1979; 36: 695.
6.
MarkleyHGWorcesterMACheronisJCD. Treatment of acute migraine with intravenous verapamil (abstract). Neurology1984; 34 (suppl):245.
7.
BraunwaldE. Mechanism of action of calcium-channel-blocking agents. N Engl J Med1982; 307: 1618–27.
8.
MeyerJSHardenbergJ. Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches. Headache1983; 23: 266–77.
9.
SmithRSchwartzA. Diltiazem prophylaxis in refractory migraine (letter). N Engl J Med1984; 310: 1327–8.
10.
MarkleyGHCheronisJCDPiephoRW. Verapamil in prophylactic therapy of migraine. Neurology1984; 34: 973–6.
11.
KazdaSTowartR. Nimodipine: A new calcium antagonistic drug with a preferential cerebrovascular action. Acta Neurochir1982; 63: 259–65.
12.
PeroutkaSJ. The pharmacology of calcium channel antagonists: A novel class of anti-migraine agents?. Headache1983; 23: 278–83.
13.
MeyerJSDowellRWalkerM. Calcium antagonists are effective in prophylactic treatment of all types of vascular headache. Ann Neurol1984; 16: 113–4.
14.
GelmersHJ. Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine. Headache1983; 23: 106–9.
15.
LouisP. A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine. Headache1981; 21: 235–9.
16.
DiamondSSchenbaumH. Flunarizine, a calcium channel blocker, in the prophylactic treatment of migraine. Headache1983; 23: 39–42.
17.
MathewNT. Prophylaxis of migraine and mixed headache; a randomized controlled study. Headache1981; 21: 105–9.
18.
PetersonRNFreundM. Effects of (H +), (Na +), (K +) and certain membrane-active drugs on glycolysis, motility, and ATP synthesis by human spermatozoa. Biol Reprod1973; 8: 350–7.
19.
DeturnerEAAparicioNJTurnerDSchwarzsteinL. Effect of two phosphodiesterase inhibitors, cyclic adenosine 3′:5′-monophosphate, and a β-blocking agent on human sperm motility. Feretil Steril1978; 29: 328–31.
20.
HongCYChaputDESaintongeDMTurnerP. The inhibitory action of procaine, (+)-propranolol and (±)-propranolol on human sperm motility: Antagonism by caffeine. Br J Clin Pharmacol1981; 12: 751–2.
21.
HongCYTurnerP. Influence of lipid solubility on the sperm immobilizing effect of β-adrenoreceptor blocking drugs. Br J Clin Pharmacol1982; 14: 269–72.
22.
ZipperJBruzzoneMEAngeloS. Effects of topically applied adrenergic blockers on fertility. Int J Fertil1982; 27 (4):242–5.
23.
ZipperJWheelerRGPottsDMRiveraM. Propranolol as a novel, effective spermicide: Preliminary findings. Br Med J1983; 287: 1245–6.
24.
PatelLGWarringtonSJPearsonRM. Propranolol concentrations in plasma after insertion into the vagina. Br Med J1983; 287: 1247–8.
